SCHEMBL25547935

SCHEMBL25547935

O=C1CCc2cc(NC(=O)c3ccc(O)c(C(=O)Nc4cnccn4)c3)ccc2N1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 1/20 0.45
▸ KMT2A Q03164 1/20 0.44
▸ CRBN Q96SW2 2/20 0.44
▸ ALDH1A2 O94788 2/20 0.42
▸ ROCK2 O75116 2/20 0.42
▸ KIF11 P52732 1/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ HDAC3 O15379 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18789762 0.88 MAP4K1 (0.51) MAP4K1KMT2ACRBNALDH1A2ROCK2
SCHEMBL25547937 0.85 MAP4K1 (0.43) MAP4K1CRBNALDH1A2ROCK2NPC1
SCHEMBL22284857 0.84 CYP3A4 (0.54) KMT2AROCK2NPC1RAB9ASMN1; SMN2
SCHEMBL30445057 0.84 CYP3A4 (0.54) KMT2AROCK2NPC1RAB9ASMN1; SMN2
SCHEMBL9378760 0.77 MAP4K1 (0.60) MAP4K1CRBNALDH1A2ROCK2KIF11
SCHEMBL26441302 0.74 MAP4K1 (0.53) MAP4K1CRBNALDH1A2KIF11SMN1; SMN2
SCHEMBL26441313 0.73 MAP4K1 (0.53) MAP4K1CRBNALDH1A2ROCK2KIF11
SCHEMBL31329494 0.73 MAP4K1 (0.51) MAP4K1CRBNALDH1A2ROCK2KIF11
SCHEMBL21646064 0.73 MAP4K1 (0.51) MAP4K1CRBNALDH1A2ROCK2KIF11
SCHEMBL31329495 0.73 MAP4K1 (0.51) MAP4K1CRBNALDH1A2ROCK2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3365819-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP disclosed
EP-3365330-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP disclosed
Send feedback